RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Zivo Bioscience Stock

Zivo Bioscience Stocks 2024

Zivo Bioscience Stocks

1.69 M

Ticker

ZIVO

ISIN

US98978N1019

In 2024, Zivo Bioscience had 1.69 M outstanding stocks, a 0% change from the 1.69 M stocks in the previous year.

The Zivo Bioscience Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2025e1.69
2024e1.69
20231.69
20221.57
20211.27
20200.85
20190.58
20180.33
20170.29
20160.28
20150.27
20140.38
20130.23
20120.21
20110.2
20100.18
20090.15
20080.11
20070.09
20060.07
20050.04
20040.02

Zivo Bioscience shares outstanding

The number of shares was Zivo Bioscience in 2023 — This indicates how many shares 1.69 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Zivo Bioscience earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Zivo Bioscience's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Zivo Bioscience’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zivo Bioscience's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Zivo Bioscience Aktienanalyse

What does Zivo Bioscience do?

Zivo Bioscience Inc is a biotechnology company that was founded in 2008. The company is based in Keego Harbor, Michigan, USA. It specializes in the development and production of animal feed, nutritional supplements, and medications from plant sources. The founders of the company recognized the potential of microalgae as a food source for animals and began conducting extensive research campaigns on this topic. The algae are rich in proteins, Omega-3, vitamins, and minerals, making them an excellent food source for livestock. Zivo Bioscience Inc's business model is based on the production of food and nutritional supplements for livestock. The company's goal is to offer a cost-effective alternative to conventional animal feed products that have higher quality and nutritional value. The company holds several patents for its technology, which allows it to develop these high-quality food products. Zivo Bioscience Inc has three different business segments: animal feed, human nutritional supplements, and pharmaceutical products. The animal feed segment is the company's largest business segment. The products include cattle feed, poultry feed, and swine feed. The human nutritional supplements are high-quality supplements made from the company's crop plants. These include products such as Omega-3 supplements, immune system boosters, and antioxidants. The pharmaceutical segment of the company focuses on the development of medications for various applications, particularly for the fight against inflammation and cancer. Zivo Bioscience Inc has launched several plant-based products on the market. The products for livestock include ZivoProtein and ZivoAlgae. ZivoProtein is a high-quality protein derived from microalgae that can be used in various animal feed products. ZivoAlgae is a blend of different microalgae species that can be used as a nutritional supplement for livestock. The products for human nutritional supplements include ZivoChews, ZivoBar, and ZivoEPA+DHA. ZivoChews and ZivoBar are snack products made from plant sources and contain various nutrients, including proteins, Omega-3 fatty acids, and antioxidants. ZivoEPA+DHA is a high-quality Omega-3 supplement. In the pharmaceutical field, the company has developed ZivoBort and ZivoBurster. ZivoBort is a potential medication aimed at fighting inflammation, while ZivoBurster is a potential medication for combating cancer. Zivo Bioscience Inc has established several business relationships in recent years to sell its products. The company has formed partnerships with animal feed company NutriQuest and pharmaceutical company PharmCoRx. Zivo Bioscience Inc has also collaborated with the University of Arizona and the University of Massachusetts to conduct research in the field of plant biotechnology. Overall, Zivo Bioscience Inc is an innovative company specializing in the development of high-quality food and nutritional supplements from plant sources. The company has already launched several products on the market and is working on developing new products. With its research efforts and business relationships, the company is well-positioned to realize its vision of cost-effective and nutritious animal feed products. Zivo Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Zivo Bioscience's Shares Outstanding

Zivo Bioscience's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Zivo Bioscience’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Zivo Bioscience’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Zivo Bioscience’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Zivo Bioscience stock

How many stocks are there of Zivo Bioscience?

The current number of stocks of Zivo Bioscience is 1.69 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Zivo Bioscience are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Zivo Bioscience evolved in recent years?

The number of shares of Zivo Bioscience has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Zivo Bioscience as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Zivo Bioscience?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Zivo Bioscience pay?

Over the past 12 months, Zivo Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zivo Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Zivo Bioscience?

The current dividend yield of Zivo Bioscience is .

When does Zivo Bioscience pay dividends?

Zivo Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Zivo Bioscience?

Zivo Bioscience paid dividends every year for the past 0 years.

What is the dividend of Zivo Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Zivo Bioscience located?

Zivo Bioscience is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Zivo Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zivo Bioscience from 12/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/11/2024.

When did Zivo Bioscience pay the last dividend?

The last dividend was paid out on 12/11/2024.

What was the dividend of Zivo Bioscience in the year 2023?

In the year 2023, Zivo Bioscience distributed 0 USD as dividends.

In which currency does Zivo Bioscience pay out the dividend?

The dividends of Zivo Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Zivo Bioscience

Our stock analysis for Zivo Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zivo Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.